To the content
3 . 2021

Risk assessment of glucoamylase and xylanase complex from Aspergillus awamori Xyl T-15

Abstract

The introduction of methods for food production using microbial synthesis, including those obtained with the help of genetically modified (GM) microorganisms, at the present stage, allows to increase production volumes and reduce the cost of food. At the same time, such products in accordance with TR CU 021/2011 “On food safety” are classified as a “novel food”» and can be placed on the market only after its risk estimation for health. The emergence of new data and research methods in the last years has made it necessary to improve the risk assessment system for this category of food.

The aim of the research is to develope risk assessment approaches of food obtained by microbial synthesis on the example of the GM strain Aspergillus awamori Xyl T-15 and the enzyme preparation (EP) (a complex of glucoamylase and xylanase) produced by it.

Material and methods. Outbred ICR mice (CD-1) and Wistar rats (males and females) were used in the experimental studies. Investigations of GM strain A. awamori Xyl T-15 virulence and its ability to disseminate internal organs have been carried out. Acute and subacute (during 80 days) toxicity of EP (a complex of glucoamylase and xylanase) have been studied.

Results. The presented experimental data allow us to make a conclusion about the avirulence of the A. awamori Xyl T-15 strain, the lack of ability to disseminate internal organs (invasiveness). At the same time, the strain is characterized by the ability to produce mycotoxins (ochratoxin, fumonisin B2, T-2 and HT-2 toxins). The EP, a complex of glucoamylase and xylanase from A. awamori Xyl T-15, has a low oral acute toxicity for rats (LD50>5000 mg/kg). Intragastric EP administration at doses of 10, 100 and 1000 mg/kg of body weight during 80 days had not revealed adversely affect on the rate of weight gain in animals, indicators of anxiety and cognitive function, and some studied biochemical indicators. At a dose of 100 mg/kg b.w. or more, there were changes in the relative mass of organs (lungs, kidneys, adrenal glands), small shifts in the parameters of erythropoiesis and leukocyte formula, at a dose of 1000 mg/kg b.w. - an increase in oxidative DNA destruction. The most pronounced and dose-dependent was the effect of the EP on hepatocyte apoptosis. According to this indicator, the not observed adverse effect level (NOAEL) for EP is not more than 100 mg/kg b.w. in terms of protein. The main target organ for the toxic effect of EP is the liver.

Conclusion. The data obtained demonstrate the necessity to conduct an additional analysis of the risks of possible negative effects of EP, namely, to study its impact on the gut microbiocenosis and the immune status of experimental animals, to analyze the presence of determinants of pathogenicity and antibiotic resistance, DNA of selective marker genes of A. awamori Xyl T-15 strain by PCR analysis and DNA sequencing methods.

Keywords:novel food, enzyme preparation, genetically modified microorganism, producer strain, virulence, toxicological and biochemical studies

Funding. The research was carried out at the expense of the subsidy for the implementation of the state task № 0529-2019-0057.

Conflict of interest. The authors declare no conflict of interest.

For citation: Bagryantseva O.V., Gmoshinski I.V., Shipelin V.A., Tsurikova N.V., Sheveleva S.A., Shumakova A.A., Musaeva A.D., Trushina E.N., Mustafina O.K., Soto C.J., Minaeva L.P., Sedova I.B., Selifanov A.V., Sokolov I.E., Kolobanov A.I., Khotimchenko S.A. Risk assessment of glucoamylase and xylanase complex from Aspergillus awamori Xyl T-15. Voprosy pitaniia [Problems of Nutrition]. 2021; 90 (3): 28-39. DOI: https://doi.org/10.33029/0042-8833-2021-90-3-28-39 (in Russian)

References

1. Bagryantseva O.V. Justification of the need to develop measures to manage risks associated with the use of food products produced using microbial synthesis. Voprosy pitaniia [Problems of Nutrition]. 2020; 89 (2): 64–76. DOI: https://doi.org/10.24411/0042-8833-2020-10017 (in Russian)

2. Rozhkova A.M., Sereda A.S., Tsurikova N.V., Nurtaeva A.K., Semenova M.V., Rimareva L.V., et al. Creation of a heterologous gene expression system on the basis of Aspergillus awamori recombinant strain. Prikladnaya biokhimiya i mikrobiologiya [Applied Biochemistry and Microbiology]. 2011; 47 (3): 279–87. DOI: https://doi.org/10.1134/S0003683811030124 (in English)

3. Rimareva L.V., Tsurikova N.V., Kostyleva E.V., Sereda A.S. Recombinant strain of filamentous fungus Aspergillus awamori - producer of a complex of enzymes glucoamylase and xylanase. RU Patent No. 2457246, priority dated 21.03.2011. (in Russian)

4. Guide for the care and use of laboratory animals. 8th ed. Committee for the Update of the Guide for the Care and Use of Laboratory Animals; Institute for Laboratory Animal Research (ILAR); Division on Earth and Life Studies (DELS); National Research Council of the national academies. Washington: National Academies Press, 2011.

5. Pivovarov Yu.P., Myalina L.I., Korolik V.V., et al. Criteria for evaluating the pathogenic properties of producer strains proposed for use in the microbiological synthesis industry. Methodical instructions. Moscow, 1992: 22 p. (in Russian)

6. Gause G. F. Determinant of actinomycetes: Genera of Streptomyces, Streptoverticillium, Chainia. Moscow: Kniga po Trebovaniyu, 2014. 248 p. ISBN 978-5-458-47107-7. (in Russian)

7. Loskutova L.V., Dubrovina N.I., Markel’ A.L. Comparative analysis of the persistence of a conditioned passive avoidance reflex in rats with different forms of inherited hypertension. Neurosci Behav Physiol. 2007; 37 (6): 577–82. DOI: https://doi.org/10.1007/s11055-007-0055-y

8. Raspopov R.V., Trushina E.N., Gmoshinsky I.V., Khotimchenko S.A. Bioavailability of iron oxide nanoparticles when used in food. Results of experiments on rats. Voprosy pitaniia [Problems of Nutrition]. 2011; 80 (3): 25–30. (in Russian)

9. Golubkina N.A. Fluorometric method for the determination of selenium. Zhurnal analiticheskoy khimii [Journal of Analitical Chemistry]. 1995; 50 (8): 492–7. (in Russian)

10. De Martinis B.S., Bianchi M.L.P. Methodology for urinary 8-hydroxy-2’-deoxyguanosine analysis by HPLC with electrochemical detection. Pharmacol Res. 2002; 46 (2): 129–31. DOI: https://doi.org/10.1016/s1043-6618(02)00080-4

11. Gallo A., Ferrara M., Perrone G. Phylogenetic study of polyketide synthases and nonribosomal peptide synthetases involved in the biosynthesis of mycotoxins. Toxins. 2013; 5: 717–42. DOI: https://doi.org/10.3390/toxins5040717

12. Guidance on the risk assessment of genetically modified microorganisms and their products intended for food and feed use. CAC/GL 46-2003: 13 p. URL: http://www.fao.org/fao-who-codexalimentarius/en/

13. Guidance on the risk assessment of genetically modified microorganisms and their products intended for food and feed use. EFSA J. 2011; 9 (6): 2193. URL: http://www.efsa.europa.eu

14. Principles and methods for the risk assessment of chemicals in food. Environmental health criteria 240. World Health Organization, 2009. Updated in 2020: 34 p. ISBN: 9789241572408.

15. Ricci A., Allende A., Bolton D., Chemaly M., Davies R., Gironeset R., et al. Statement on the update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 7: suitability of taxonomic units notified to EFSA until September 2017. EFSA BIOHAZ Panel (EFSA Panel on Biological Hazards). EFSA J. 2018; 16 (1): 5131. DOI: https://doi.org/10.2903/j.efsa.2018.5131

16. Guidance on safety evaluation of sources of nutrients and bioavailability of nutrient from the sources. EFSA J. 2018; 16 (6): 5294. DOI: https://doi.org/10.2903/j.efsa.2018.5294.

17. Silano V., Baviera B.J.M., Bolognesi C., Bruschweiler B.J., Cocconcelli P.S., Crebelli R., et al. Statement on the characterisation of microorganisms used for the production of food enzymes. EFSA CEP Panel (EFSA Panel on Food Contact Materials, Enzymes and Processing Aids). EFSA J. 2019; 17 (6): 5741. DOI: https://doi.org/10.2903/j.efsa.2019.5741

18. Analysis of JECFA’s draft guideline on «Evaluation of enzyme preparations used in the manufacture of foods». In: EFSA Supporting publication 2020. EN-1795: 8 p. DOI: https://doi.org/10.2903/sp.efsa.2020.EN-1795

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

SCImago Journal & Country Rank
Scopus CiteScore
CHIEF EDITOR
CHIEF EDITOR
Viktor A. Tutelyan
Full Member of the Russian Academy of Sciences, Doctor of Medical Sciences, Professor, Scientific Director of the Federal Research Centre of Nutrition, Biotechnology and Food Safety (Moscow, Russia)

Journals of «GEOTAR-Media»